Upjohn


Also found in: Thesaurus, Wikipedia.

Up·john

 (ŭp′jŏn′), Richard 1802-1878.
British-born American architect who was a leader of the Gothic revival. His designs include Trinity Church in New York City (1846).
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.Upjohn - United States architect (born in England) (1802-1878)
Mentioned in ?
References in classic literature ?
This was a man of letters, named Leonard Upjohn, whom Philip had met once or twice with Cronshaw in the cafes of the Quarter.
His decision to come to England was caused directly by an announcement from Leonard Upjohn that a publisher had consented to print the poems.
Upjohn had promised to write a signed article about them, and he would ask his friends who reviewed to do their best.
Michael Goettler, head of PfizerA's off-patented drug business Upjohn, will serve as CEO, while Heather Bresch, the current CEO of Mylan, will leave the company.
Mylan's, recently announced plan to combine with Pfizer's off-patent branded and generic drug business, Upjohn, exemplifies the trend of reshaping product portfolios to supplement growth.
Mylan (MYL), which recently announced a definitive agreement to combine with Pfizer's (PFE) Upjohn unit, markets branded and generic versions of the epinephrine injectors.
agreed last month to combine its off-patent drug business, Upjohn, with generic drug maker Mylan NV.
Summary: Mumbai (Maharashtra) [India], July 31 (ANI): Netherlands-based Mylan NV and US-based Pfizer Inc have announced a definitive agreement to combine Mylan with Upjohn, Pfizer's off-patent branded and generic established medicines business, creating a new global pharmaceutical company.
M2 PHARMA-July 31, 2019-Pfizer to integrate Upjohn with Mylan to establish new global pharmaceutical company
M2 EQUITYBITES-July 31, 2019-Pfizer to integrate Upjohn with Mylan to establish new global pharmaceutical company
Morgan Stanley downgraded Pfizer Inc (NYSE:PFE) Tuesday after the drug company announced the spinoff of its Upjohn division on Monday, sending its stock downward.
Pfizer's Upjohn, which sells one-time blockbusters like Viagra and Lipitor that have lost patent protection, will be spun off and then it will combine with Mylan, a $10 billion company.